References
- EMCDDA. Europol 2013 Annual Report on the implementation of Council Decision. 2005/387/JHA, http://www.emcdda.europa.eu/attachements.cfm/att_229598_EN_TDAN14001ENN.pdf. Accessed 2 April 2015.
- Kennerly PS, Corbin TR, Murphy CE. Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker. J Pharm Sci 2014; 103:3834–3842.
- EMCDDA. Europol 2011 Annual Report on the implementation of Council Decision. 2005/387/JHA. https://www.europol.europa.eu/sites/default/files/publications/emcdda-europol_annual_report_2011_2012_final.pdf 2011. Accessed 2 April 2015.
- http://www.bluelight.org/vb/archive/index.php/t-520608.html. Accessed 2 April 2015.
- Krueger J, Sachs H, Musshoff F, Dame T, Schaeper J, Schwerer M, et al.First detection of ethylphenidate in human fatalities after ethylphenidate intake. Forensic Sci Int 2014; 243:126–129.